Chiesi’s Trimbow recommended for use within NHS Scotland
The SMC approval brings much-needed boost to asthma sufferers across Scotland
Read More
Author: John Pinching
Sanofi provides update on amcenestrant
The company’s clinical development programme is to be discontinued following a recent evaluation
Read More
LifeArc and Great Ormond Street Hospital charity award £1.3m to tackle diseases
Funds will allow researchers to focus on improving the lives of children with rare conditions
Read More
Lynparza in combination with abiraterone granted priority review in US
New therapy is aimed at patients with metastatic castration-resistant prostate cancer
Read More
Evonetix commences access programme for synthesised DNA
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
